What is Daktari Diagnostics?
Daktari Diagnostics is a company focused on developing innovative solutions within the healthcare and diagnostics space. While specific details about its core technology or market niche are not provided in the generic data, its funding history suggests a trajectory typical of companies aiming for significant market penetration and technological advancement. The company has attracted considerable investment across various stages, indicating strong investor confidence in its long-term vision and potential for growth. The nature of its funding rounds, from early-stage private equity to later-stage Series D, points to a company that has successfully navigated product development and market scaling phases.
How much funding has Daktari Diagnostics raised?
Daktari Diagnostics has raised a total of $79.1M across 8 funding rounds:
Series A
$2.8M
Private Equity
$820K
Private Equity
$1.8M
Debt
$1.2M
Series B
$10M
Private Equity
$20M
Series C
$20M
Series D
$22.5M
Series A (2009): $2.8M with participation from LaunchPad Venture Group, Hub Angels Investment Group, Mass Medical Angels, Norwich Ventures, and Boston Harbor Angels
Private Equity (2010): $820K, investors not publicly disclosed
Private Equity (2010): $1.8M, investors not publicly disclosed
Debt (2011): $1.2M, investors not publicly disclosed
Series B (2011): $10M backed by Merck & Co and Norwich Ventures
Private Equity (2013): $20M with participation from Norwich Ventures
Series C (2014): $20M, investors not publicly disclosed
Series D (2015): $22.5M supported by Merck Global Health Innovation Fund and Norwich Ventures
Key Investors in Daktari Diagnostics
Norwich Ventures
Norwich Ventures is a specialized venture capital firm established in 2004, focusing on early-stage medtech investments. The firm seeks to support entrepreneurs developing innovative technologies that address significant unmet medical needs.
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund, associated with Merck & Co., Inc., invests in innovative healthcare solutions, including prescription medicines, biologic therapies, vaccines, and animal health products, aiming to drive advancements in global health.
LaunchPad Venture Group
Launchpad Venture Group is a network of angel investors focused on providing financial and human capital investments in early-stage tech and science-driven startups based in New England.
What's next for Daktari Diagnostics?
With a history of significant capital infusions, Daktari Diagnostics is positioned for continued expansion and innovation. The major strategic investment signals a new phase of growth, likely focused on scaling operations, further research and development, or market penetration. The company's ability to attract repeat backing from sophisticated investors like Norwich Ventures and Merck Global Health Innovation Fund suggests a robust business model and a clear path toward achieving its strategic objectives. Future developments may include product commercialization, strategic partnerships, or further technological advancements to solidify its market position.
See full Daktari Diagnostics company page
